<?xml version="1.0" ?>
<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2024//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_240101.dtd">
<PubmedArticleSet>
<PubmedArticle><MedlineCitation Status="PubMed-not-MEDLINE" Owner="NLM"><PMID Version="1">37869162</PMID><DateRevised><Year>2023</Year><Month>11</Month><Day>03</Day></DateRevised><Article PubModel="Electronic-eCollection"><Journal><ISSN IssnType="Print">2296-858X</ISSN><JournalIssue CitedMedium="Print"><Volume>10</Volume><PubDate><Year>2023</Year></PubDate></JournalIssue><Title>Frontiers in medicine</Title><ISOAbbreviation>Front Med (Lausanne)</ISOAbbreviation></Journal><ArticleTitle>Clinical and pulmonary function analysis in long-COVID revealed that long-term pulmonary dysfunction is associated with vascular inflammation pathways and metabolic syndrome.</ArticleTitle><Pagination><StartPage>1271863</StartPage><MedlinePgn>1271863</MedlinePgn></Pagination><ELocationID EIdType="pii" ValidYN="Y">1271863</ELocationID><ELocationID EIdType="doi" ValidYN="Y">10.3389/fmed.2023.1271863</ELocationID><Abstract><AbstractText Label="INTRODUCTION" NlmCategory="UNASSIGNED">Long-term pulmonary dysfunction (L-TPD) is one of the most critical manifestations of long-COVID. This lung affection has been associated with disease severity during the acute phase and the presence of previous comorbidities, however, the clinical manifestations, the concomitant consequences and the molecular pathways supporting this clinical condition remain unknown. The aim of this study was to identify and characterize L-TPD in patients with long-COVID and elucidate the main pathways and long-term consequences attributed to this condition by analyzing clinical parameters and functional tests supported by machine learning and serum proteome profiling.</AbstractText><AbstractText Label="METHODS" NlmCategory="UNASSIGNED">Patients with L-TPD were classified according to the results of their computer-tomography (CT) scan and diffusing capacity of the lungs for carbon monoxide adjusted for hemoglobin (DLCOc) tests at 4 and 12-months post-infection.</AbstractText><AbstractText Label="RESULTS" NlmCategory="UNASSIGNED">Regarding the acute phase, our data showed that L-TPD was favored in elderly patients with hypertension or insulin resistance, supported by pathways associated with vascular inflammation and chemotaxis of phagocytes, according to computer proteomics. Then, at 4-months post-infection, clinical and functional tests revealed that L-TPD patients exhibited a restrictive lung condition, impaired aerobic capacity and reduced muscular strength. At this time point, high circulating levels of platelets and CXCL9, and an inhibited FCgamma-receptor-mediated-phagocytosis due to reduced Fc&#x3b3;RIII (CD16) expression in CD14+ monocytes was observed in patients with L-TPD. Finally, 1-year post infection, patients with L-TPD worsened metabolic syndrome and augmented body mass index in comparison with other patient groups.</AbstractText><AbstractText Label="DISCUSSION" NlmCategory="UNASSIGNED">Overall, our data demonstrated that CT scan and DLCOc identified patients with L-TPD after COVID-19. This condition was associated with vascular inflammation and impair phagocytosis of virus-antibody immune complexes by reduced Fc&#x3b3;RIII expression. In addition, we conclude that COVID-19 survivors required a personalized follow-up and adequate intervention to reduce long-term sequelae and the appearance of further metabolic diseases.</AbstractText><CopyrightInformation>Copyright &#xa9; 2023 Sanhueza, Vidal, Hernandez, Henriquez-Beltran, Cabrera, Quiroga, Antilef, Aguilar, Castillo, Llerena, Fraga Figueroa, Nazal, Castro, Lagos, Moreno, Lastra, Gajardo, Garc&#xe9;s, Riffo, Buchert, Sanhueza, Ormaz&#xe1;ba, Saldivia, Vargas, Nourdin, Koch, Zu&#xf1;iga, Lamperti, Bustos, Guzm&#xe1;n-Guti&#xe9;rrez, Tapia, Ferrada, Cerda, Woehlbier, Riquelme, Yuseff, Mu&#xf1;oz Ramirez, Lombardi, De Gonzalo-Calvo, Salomon, Verdugo, Qui&#xf1;ones, Colombo, Barr&#xed;a, Labarca and Nova-Lamperti.</CopyrightInformation></Abstract><AuthorList CompleteYN="Y"><Author ValidYN="Y" EqualContrib="Y"><LastName>Sanhueza</LastName><ForeName>Sergio</ForeName><Initials>S</Initials><AffiliationInfo><Affiliation>Molecular and Translational Immunology Laboratory, Department of Clinical Biochemistry and Immunology, Pharmacy Faculty, University of Concepci&#xf3;n, Concepci&#xf3;n, Chile.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Vidal</LastName><ForeName>Mabel A</ForeName><Initials>MA</Initials><AffiliationInfo><Affiliation>Molecular and Translational Immunology Laboratory, Department of Clinical Biochemistry and Immunology, Pharmacy Faculty, University of Concepci&#xf3;n, Concepci&#xf3;n, Chile.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Facultad de Ingenier&#xed;a, Dise&#xf1;o y Arquitectura, Universidad San Sebasti&#xe1;n, Concepci&#xf3;n, Chile.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y" EqualContrib="Y"><LastName>Hernandez</LastName><ForeName>Mauricio A</ForeName><Initials>MA</Initials><AffiliationInfo><Affiliation>Division of Biotechnology, MELISA Institute, San Pedro de la Paz, Chile.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Henriquez-Beltran</LastName><ForeName>Mario E</ForeName><Initials>ME</Initials><AffiliationInfo><Affiliation>Molecular and Translational Immunology Laboratory, Department of Clinical Biochemistry and Immunology, Pharmacy Faculty, University of Concepci&#xf3;n, Concepci&#xf3;n, Chile.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>N&#xfa;cleo de Investigaci&#xf3;n en Ciencias de la Salud, Universidad Adventista de Chile, Chill&#xe1;n, Chile.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Kinesiology School, Escuela de Kinesiolog&#xed;a, Facultad de Salud, Universidad Santo Tom&#xe1;s, Los &#xc1;ngeles, Chile.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Translational Research in Respiratory Medicine, University Hospital Arnau de Vilanova and Santa Maria, IRBLleida, Lleida, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cabrera</LastName><ForeName>Camilo</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Molecular and Translational Immunology Laboratory, Department of Clinical Biochemistry and Immunology, Pharmacy Faculty, University of Concepci&#xf3;n, Concepci&#xf3;n, Chile.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Quiroga</LastName><ForeName>Romina</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Molecular and Translational Immunology Laboratory, Department of Clinical Biochemistry and Immunology, Pharmacy Faculty, University of Concepci&#xf3;n, Concepci&#xf3;n, Chile.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Antilef</LastName><ForeName>B&#xe1;rbara E</ForeName><Initials>BE</Initials><AffiliationInfo><Affiliation>Molecular and Translational Immunology Laboratory, Department of Clinical Biochemistry and Immunology, Pharmacy Faculty, University of Concepci&#xf3;n, Concepci&#xf3;n, Chile.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Aguilar</LastName><ForeName>Kevin P</ForeName><Initials>KP</Initials><AffiliationInfo><Affiliation>Molecular and Translational Immunology Laboratory, Department of Clinical Biochemistry and Immunology, Pharmacy Faculty, University of Concepci&#xf3;n, Concepci&#xf3;n, Chile.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Castillo</LastName><ForeName>Daniela A</ForeName><Initials>DA</Initials><AffiliationInfo><Affiliation>Molecular and Translational Immunology Laboratory, Department of Clinical Biochemistry and Immunology, Pharmacy Faculty, University of Concepci&#xf3;n, Concepci&#xf3;n, Chile.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Llerena</LastName><ForeName>Faryd J</ForeName><Initials>FJ</Initials><AffiliationInfo><Affiliation>Molecular and Translational Immunology Laboratory, Department of Clinical Biochemistry and Immunology, Pharmacy Faculty, University of Concepci&#xf3;n, Concepci&#xf3;n, Chile.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Fraga Figueroa</LastName><ForeName>Marco</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Molecular and Translational Immunology Laboratory, Department of Clinical Biochemistry and Immunology, Pharmacy Faculty, University of Concepci&#xf3;n, Concepci&#xf3;n, Chile.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nazal</LastName><ForeName>Mauricio</ForeName><Initials>M</Initials><AffiliationInfo><Affiliation>Molecular and Translational Immunology Laboratory, Department of Clinical Biochemistry and Immunology, Pharmacy Faculty, University of Concepci&#xf3;n, Concepci&#xf3;n, Chile.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Castro</LastName><ForeName>Eritson</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Molecular and Translational Immunology Laboratory, Department of Clinical Biochemistry and Immunology, Pharmacy Faculty, University of Concepci&#xf3;n, Concepci&#xf3;n, Chile.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lagos</LastName><ForeName>Paola</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Molecular and Translational Immunology Laboratory, Department of Clinical Biochemistry and Immunology, Pharmacy Faculty, University of Concepci&#xf3;n, Concepci&#xf3;n, Chile.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Moreno</LastName><ForeName>Alexa</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Molecular and Translational Immunology Laboratory, Department of Clinical Biochemistry and Immunology, Pharmacy Faculty, University of Concepci&#xf3;n, Concepci&#xf3;n, Chile.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lastra</LastName><ForeName>Jaime J</ForeName><Initials>JJ</Initials><AffiliationInfo><Affiliation>Internal Medicine Department, Hospital Guillermo Grant Benavente and Medicine Faculty, University of Concepci&#xf3;n, Concepci&#xf3;n, Chile.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Gajardo</LastName><ForeName>Jorge</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>Internal Medicine Department, Hospital Guillermo Grant Benavente and Medicine Faculty, University of Concepci&#xf3;n, Concepci&#xf3;n, Chile.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Garc&#xe9;s</LastName><ForeName>Pamela</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Internal Medicine Department, Hospital Guillermo Grant Benavente and Medicine Faculty, University of Concepci&#xf3;n, Concepci&#xf3;n, Chile.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Riffo</LastName><ForeName>Benilde</ForeName><Initials>B</Initials><AffiliationInfo><Affiliation>PreveGen Laboratory, Concepci&#xf3;n, Chile.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Buchert</LastName><ForeName>Jorge</ForeName><Initials>J</Initials><AffiliationInfo><Affiliation>PreveGen Laboratory, Concepci&#xf3;n, Chile.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Sanhueza</LastName><ForeName>Roc&#xed;o</ForeName><Initials>R</Initials><AffiliationInfo><Affiliation>Kinesiology School, Escuela de Kinesiolog&#xed;a, Facultad de Salud, Universidad Santo Tom&#xe1;s, Los &#xc1;ngeles, Chile.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ormaz&#xe1;ba</LastName><ForeName>Valeska</ForeName><Initials>V</Initials><AffiliationInfo><Affiliation>Department of Pharmacology, Faculty of Biological Sciences, University of Concepci&#xf3;n, Concepci&#xf3;n, Chile.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Saldivia</LastName><ForeName>Pablo</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Division of Biotechnology, MELISA Institute, San Pedro de la Paz, Chile.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Vargas</LastName><ForeName>Cristian</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Division of Biotechnology, MELISA Institute, San Pedro de la Paz, Chile.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nourdin</LastName><ForeName>Guillermo</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Division of Biotechnology, MELISA Institute, San Pedro de la Paz, Chile.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Koch</LastName><ForeName>Elard</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Division of Biotechnology, MELISA Institute, San Pedro de la Paz, Chile.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Zu&#xf1;iga</LastName><ForeName>Felipe A</ForeName><Initials>FA</Initials><AffiliationInfo><Affiliation>Molecular and Translational Immunology Laboratory, Department of Clinical Biochemistry and Immunology, Pharmacy Faculty, University of Concepci&#xf3;n, Concepci&#xf3;n, Chile.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lamperti</LastName><ForeName>Liliana</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>Molecular and Translational Immunology Laboratory, Department of Clinical Biochemistry and Immunology, Pharmacy Faculty, University of Concepci&#xf3;n, Concepci&#xf3;n, Chile.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Bustos</LastName><ForeName>Paula</ForeName><Initials>P</Initials><AffiliationInfo><Affiliation>Molecular and Translational Immunology Laboratory, Department of Clinical Biochemistry and Immunology, Pharmacy Faculty, University of Concepci&#xf3;n, Concepci&#xf3;n, Chile.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Guzm&#xe1;n-Guti&#xe9;rrez</LastName><ForeName>Enrique</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Molecular and Translational Immunology Laboratory, Department of Clinical Biochemistry and Immunology, Pharmacy Faculty, University of Concepci&#xf3;n, Concepci&#xf3;n, Chile.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Tapia</LastName><ForeName>Claudio A</ForeName><Initials>CA</Initials><AffiliationInfo><Affiliation>Molecular and Translational Immunology Laboratory, Department of Clinical Biochemistry and Immunology, Pharmacy Faculty, University of Concepci&#xf3;n, Concepci&#xf3;n, Chile.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Ferrada</LastName><ForeName>Luciano</ForeName><Initials>L</Initials><AffiliationInfo><Affiliation>CMA B&#xed;o-B&#xed;o - Advanced Microscopy Center, University of Concepci&#xf3;n, Concepci&#xf3;n, Chile.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Cerda</LastName><ForeName>Gustavo</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>CMA B&#xed;o-B&#xed;o - Advanced Microscopy Center, University of Concepci&#xf3;n, Concepci&#xf3;n, Chile.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Woehlbier</LastName><ForeName>Ute</ForeName><Initials>U</Initials><AffiliationInfo><Affiliation>Center for Integrative Biology, Faculty of Sciences, Universidad Mayor, Santiago, Chile.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Riquelme</LastName><ForeName>Erick</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Faculty of Medicine, Pontifical Catholic University of Chile, Santiago, Chile.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Yuseff</LastName><ForeName>Maria-Isabel</ForeName><Initials>MI</Initials><AffiliationInfo><Affiliation>Facultad de Ciencias Biol&#xf3;gicas, Pontificia Universidad Cat&#xf3;lica de Chile, Santiago, Chile.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Mu&#xf1;oz Ramirez</LastName><ForeName>Braulio A</ForeName><Initials>BA</Initials><AffiliationInfo><Affiliation>Department of Pharmacology and Toxicology, School of Medicine, Indiana University Bloomington, Bloomington, IN, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Lombardi</LastName><ForeName>Giovanna</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Peter Gorer Department of Immunobiology, School of Immunology and Microbial Sciences, Faculty of Life Sciences and Medicine, King's College London, London, United Kingdom.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>De Gonzalo-Calvo</LastName><ForeName>David</ForeName><Initials>D</Initials><AffiliationInfo><Affiliation>Translational Research in Respiratory Medicine, University Hospital Arnau de Vilanova and Santa Maria, IRBLleida, Lleida, Spain.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>CIBER of Respiratory Diseases (CIBERES), Institute of Health Carlos III, Madrid, Spain.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Salomon</LastName><ForeName>Carlos</ForeName><Initials>C</Initials><AffiliationInfo><Affiliation>Exosome Biology Laboratory, Centre for Clinical Diagnostics, UQ Centre for Clinical Research, Royal Brisbane and Women's Hospital, Medicine and Biomedical Science Faculty, The University of Queensland, Brisbane, QLD, Australia.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Verdugo</LastName><ForeName>Ricardo A</ForeName><Initials>RA</Initials><AffiliationInfo><Affiliation>Instituto de Investigaci&#xf3;n Interdisciplinaria y Escuela de Medicina, Universidad de Talca, Talca, Chile.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Qui&#xf1;ones</LastName><ForeName>Luis A</ForeName><Initials>LA</Initials><AffiliationInfo><Affiliation>Department of Basic-Clinical Oncology, Faculty of Medicine, University of Chile, Santiago, Chile.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Department of Pharmaceutical Sciences and Technology, Faculty of Chemical and Pharmaceutical Sciences, University of Chile, Santiago, Chile.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Latin American Network for Implementation and Validation of Clinical Pharmacogenomics Guidelines (RELIVAF-CYTED), Santiago, Chile.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Colombo</LastName><ForeName>Alicia</ForeName><Initials>A</Initials><AffiliationInfo><Affiliation>Department of Basic-Clinical Oncology, Faculty of Medicine, University of Chile, Santiago, Chile.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Servicio de Anatom&#xed;a Patol&#xf3;gica, Hospital Cl&#xed;nico, Universidad de Chile, Santiago, Chile.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Barr&#xed;a</LastName><ForeName>Maria I</ForeName><Initials>MI</Initials><AffiliationInfo><Affiliation>Facultad de Medicina y Ciencia, Universidad San Sebasti&#xe1;n, Puerto Montt, Chile.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Labarca</LastName><ForeName>Gonzalo</ForeName><Initials>G</Initials><AffiliationInfo><Affiliation>Molecular and Translational Immunology Laboratory, Department of Clinical Biochemistry and Immunology, Pharmacy Faculty, University of Concepci&#xf3;n, Concepci&#xf3;n, Chile.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Internal Medicine, Complejo Asistencial Dr. V&#xed;ctor R&#xed;os Ruiz, Los &#xc1;ngeles, Chile.</Affiliation></AffiliationInfo><AffiliationInfo><Affiliation>Division of Sleep and Circadian Disorders, Brigham and Women's Hospital, Harvard Medical School, Boston, MA, United States.</Affiliation></AffiliationInfo></Author><Author ValidYN="Y"><LastName>Nova-Lamperti</LastName><ForeName>Estefania</ForeName><Initials>E</Initials><AffiliationInfo><Affiliation>Molecular and Translational Immunology Laboratory, Department of Clinical Biochemistry and Immunology, Pharmacy Faculty, University of Concepci&#xf3;n, Concepci&#xf3;n, Chile.</Affiliation></AffiliationInfo></Author></AuthorList><Language>eng</Language><PublicationTypeList><PublicationType UI="D016428">Journal Article</PublicationType></PublicationTypeList><ArticleDate DateType="Electronic"><Year>2023</Year><Month>10</Month><Day>06</Day></ArticleDate></Article><MedlineJournalInfo><Country>Switzerland</Country><MedlineTA>Front Med (Lausanne)</MedlineTA><NlmUniqueID>101648047</NlmUniqueID><ISSNLinking>2296-858X</ISSNLinking></MedlineJournalInfo><KeywordList Owner="NOTNLM"><Keyword MajorTopicYN="N">COVID-19</Keyword><Keyword MajorTopicYN="N">chemokines</Keyword><Keyword MajorTopicYN="N">metabolic syndrome</Keyword><Keyword MajorTopicYN="N">pulmonary dysfunction</Keyword><Keyword MajorTopicYN="N">sequelae</Keyword><Keyword MajorTopicYN="N">vascular inflammation</Keyword></KeywordList><CoiStatement>The authors declare that the research was conducted in the absence of any commercial or financial relationships that could be construed as a potential conflict of interest. The author(s) declared that they were an editorial board member of Frontiers, at the time of submission. This had no impact on the peer review process and the final decision.</CoiStatement></MedlineCitation><PubmedData><History><PubMedPubDate PubStatus="received"><Year>2023</Year><Month>8</Month><Day>3</Day></PubMedPubDate><PubMedPubDate PubStatus="accepted"><Year>2023</Year><Month>9</Month><Day>18</Day></PubMedPubDate><PubMedPubDate PubStatus="medline"><Year>2023</Year><Month>10</Month><Day>23</Day><Hour>6</Hour><Minute>50</Minute></PubMedPubDate><PubMedPubDate PubStatus="pubmed"><Year>2023</Year><Month>10</Month><Day>23</Day><Hour>6</Hour><Minute>49</Minute></PubMedPubDate><PubMedPubDate PubStatus="entrez"><Year>2023</Year><Month>10</Month><Day>23</Day><Hour>4</Hour><Minute>49</Minute></PubMedPubDate><PubMedPubDate PubStatus="pmc-release"><Year>2023</Year><Month>10</Month><Day>6</Day></PubMedPubDate></History><PublicationStatus>epublish</PublicationStatus><ArticleIdList><ArticleId IdType="pubmed">37869162</ArticleId><ArticleId IdType="pmc">PMC10590130</ArticleId><ArticleId IdType="doi">10.3389/fmed.2023.1271863</ArticleId></ArticleIdList><ReferenceList><Reference><Citation>Morens DM, Taubenberger JK, Fauci AS. A centenary tale of two pandemics: the 1918 influenza pandemic and COVID-19. Part I. Am J Public Health. (2021) 111:1086&#x2013;94. 10.2105/AJPH.2021.306310</Citation><ArticleIdList><ArticleId IdType="doi">10.2105/AJPH.2021.306310</ArticleId><ArticleId IdType="pmc">PMC8101587</ArticleId><ArticleId IdType="pubmed">33950739</ArticleId></ArticleIdList></Reference><Reference><Citation>da Silva Torres MK, Bichara CD, de Almeida M, Vallinoto MC, Queiroz MA, Vallinoto I, et al. The Complexity of SARS-CoV-2 infection and the COVID-19 pandemic. Front Microbiol. (2022) 13:789882. 10.3389/fmicb.2022.789882</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmicb.2022.789882</ArticleId><ArticleId IdType="pmc">PMC8870622</ArticleId><ArticleId IdType="pubmed">35222327</ArticleId></ArticleIdList></Reference><Reference><Citation>Guan WJ, Liang WH, Zhao Y, Liang HR, Chen ZS, Li YM, et al. Comorbidity and its impact on 1590 patients with COVID-19 in China: a nationwide analysis. Eur Respir J. (2020) 55:2000547. 10.1183/13993003.01227-2020</Citation><ArticleIdList><ArticleId IdType="doi">10.1183/13993003.01227-2020</ArticleId><ArticleId IdType="pmc">PMC7098485</ArticleId><ArticleId IdType="pubmed">32217650</ArticleId></ArticleIdList></Reference><Reference><Citation>Fang X, Li S, Yu H, Wang P, Zhang Y, Chen Z, et al. Epidemiological, comorbidity factors with severity and prognosis of COVID-19: a systematic review and meta-analysis. Aging. (2020) 12:12493&#x2013;503. 10.18632/aging.103579</Citation><ArticleIdList><ArticleId IdType="doi">10.18632/aging.103579</ArticleId><ArticleId IdType="pmc">PMC7377860</ArticleId><ArticleId IdType="pubmed">32658868</ArticleId></ArticleIdList></Reference><Reference><Citation>Holmes E, Wist J, Masuda R, Lodge S, Nitschke P, Kimhofer T, et al. Incomplete systemic recovery and metabolic phenoreversion in post-acute-phase nonhospitalized COVID-19 patients: implications for assessment of post-acute COVID-19 syndrome. J Proteome Res. (2021) 20:3315&#x2013;29. 10.1021/acs.jproteome.1c00224</Citation><ArticleIdList><ArticleId IdType="doi">10.1021/acs.jproteome.1c00224</ArticleId><ArticleId IdType="pubmed">34009992</ArticleId></ArticleIdList></Reference><Reference><Citation>Meyer NJ, Gattinoni L, Calfee CS. Acute respiratory distress syndrome. Lancet. (2021) 398:622&#x2013;37. 10.1016/S0140-6736(21)00439-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(21)00439-6</ArticleId><ArticleId IdType="pmc">PMC8248927</ArticleId><ArticleId IdType="pubmed">34217425</ArticleId></ArticleIdList></Reference><Reference><Citation>Tomazini BM, Maia IS, Cavalcanti AB, Berwanger O, Rosa RG, Veiga VC, et al. Effect of dexamethasone on days alive and ventilator-free in patients with moderate or severe acute respiratory distress syndrome and COVID-19: the CoDEX randomized clinical trial. JAMA. (2020) 324:1307&#x2013;16. 10.1001/jama.2020.17021</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2020.17021</ArticleId><ArticleId IdType="pmc">PMC7489411</ArticleId><ArticleId IdType="pubmed">32876695</ArticleId></ArticleIdList></Reference><Reference><Citation>Brodin P. Immune determinants of COVID-19 disease presentation and severity. Nat Med. (2021) 27:28&#x2013;33. 10.1038/s41591-020-01202-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-020-01202-8</ArticleId><ArticleId IdType="pubmed">33442016</ArticleId></ArticleIdList></Reference><Reference><Citation>Consiglio CR, Cotugno N, Sardh F, Pou C, Amodio D, Rodriguez L, et al. The immunology of multisystem inflammatory syndrome in children with COVID-19. Cell. (2020) 183:968&#x2013;81. 10.1016/j.cell.2020.09.016</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2020.09.016</ArticleId><ArticleId IdType="pmc">PMC7474869</ArticleId><ArticleId IdType="pubmed">32966765</ArticleId></ArticleIdList></Reference><Reference><Citation>Mulchandani R, Lyngdoh T, Kakkar AK. Deciphering the COVID-19 cytokine storm: Systematic review and meta-analysis. Eur J Clin Invest. (2021) 51:e13429. 10.1111/eci.13429</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/eci.13429</ArticleId><ArticleId IdType="pmc">PMC7646004</ArticleId><ArticleId IdType="pubmed">33058143</ArticleId></ArticleIdList></Reference><Reference><Citation>Carsetti R, Zaffina S, Piano Mortari E, Terreri S, Corrente F, Capponi C, et al. Different innate and adaptive immune responses to SARS-CoV-2 infection of asymptomatic, mild, and severe cases. Front Immunol. (2020) 11:610300. 10.3389/fimmu.2020.610300</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fimmu.2020.610300</ArticleId><ArticleId IdType="pmc">PMC7772470</ArticleId><ArticleId IdType="pubmed">33391280</ArticleId></ArticleIdList></Reference><Reference><Citation>Blot M, Bour JB, Quenot JP, Bourredjem A, Nguyen M, Guy J, et al. The dysregulated innate immune response in severe COVID-19 pneumonia that could drive poorer outcome. J Transl Med. (2020) 18:457. 10.1186/s12967-020-02646-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12967-020-02646-9</ArticleId><ArticleId IdType="pmc">PMC7711269</ArticleId><ArticleId IdType="pubmed">33272291</ArticleId></ArticleIdList></Reference><Reference><Citation>Wilk AJ, Rustagi A, Zhao NQ, Roque J, Mart&#xed;nez-Col&#xf3;n GJ, McKechnie JL, et al. A single-cell atlas of the peripheral immune response in patients with severe COVID-19. Nat Med. (2020) 26:1070&#x2013;6. 10.1038/s41591-020-0944-y</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-020-0944-y</ArticleId><ArticleId IdType="pmc">PMC7382903</ArticleId><ArticleId IdType="pubmed">32514174</ArticleId></ArticleIdList></Reference><Reference><Citation>Varchetta S, Mele D, Oliviero B, Mantovani S, Ludovisi S, Cerino A, et al. Unique immunological profile in patients with COVID-19. Cell Mol Immunol. (2021) 18:604&#x2013;12. 10.1038/s41423-020-00557-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41423-020-00557-9</ArticleId><ArticleId IdType="pmc">PMC7557230</ArticleId><ArticleId IdType="pubmed">33060840</ArticleId></ArticleIdList></Reference><Reference><Citation>Goshua G, Pine AB, Meizlish ML, Chang CH, Zhang H, Bahel P, et al. Endotheliopathy in COVID-19-associated coagulopathy: evidence from a single-centre, cross-sectional study. Lancet Haematol. (2020) 7:e575&#x2013;82. 10.1016/S2352-3026(20)30216-7</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2352-3026(20)30216-7</ArticleId><ArticleId IdType="pmc">PMC7326446</ArticleId><ArticleId IdType="pubmed">32619411</ArticleId></ArticleIdList></Reference><Reference><Citation>Vassiliou AG, Keskinidou C, Jahaj E, Gallos P, Dimopoulou I, Kotanidou A, et al. ICU admission levels of endothelial biomarkers as predictors of mortality in critically Ill COVID-19 patients. Cells. (2021) 10:186. 10.3390/cells10010186</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/cells10010186</ArticleId><ArticleId IdType="pmc">PMC7832393</ArticleId><ArticleId IdType="pubmed">33477776</ArticleId></ArticleIdList></Reference><Reference><Citation>Drakos S, Chatzantonis G, Bietenbeck M, Evers G, Schulze AB, Mohr M, et al. A cardiovascular magnetic resonance imaging-based pilot study to assess coronary microvascular disease in COVID-19 patients. Sci Rep. (2021) 11:15667. 10.1038/s41598-021-95277-z</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-021-95277-z</ArticleId><ArticleId IdType="pmc">PMC8329060</ArticleId><ArticleId IdType="pubmed">34341436</ArticleId></ArticleIdList></Reference><Reference><Citation>Arunachalam PS, Wimmers F, Mok CK, Perera R, Scott M, Hagan T, et al. Systems biological assessment of immunity to mild versus severe COVID-19 infection in humans. Science. (2020) 369:1210&#x2013;20. 10.1126/science.abc6261</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/science.abc6261</ArticleId><ArticleId IdType="pmc">PMC7665312</ArticleId><ArticleId IdType="pubmed">32788292</ArticleId></ArticleIdList></Reference><Reference><Citation>Lucas C, Wong P, Klein J, Castro TB, Silva J, Sundaram M, et al. Longitudinal analyses reveal immunological misfiring in severe COVID-19. Nature. (2020) 584: 463&#x2013;9.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7477538</ArticleId><ArticleId IdType="pubmed">32717743</ArticleId></ArticleIdList></Reference><Reference><Citation>Vabret N, Britton GJ, Gruber C, Hegde S, Kim J, Kuksin M, et al. Immunology of COVID-19: Current State of the Science. Immunity. (2020) 52:910&#x2013;41.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC7200337</ArticleId><ArticleId IdType="pubmed">32505227</ArticleId></ArticleIdList></Reference><Reference><Citation>Klok FA, Kruip M, van der Meer NJ, Arbous MS, Gommers D, Kant KM, et al. Confirmation of the high cumulative incidence of thrombotic complications in critically ill ICU patients with COVID-19: An updated analysis. Thromb Res. (2020) 191:148&#x2013;50. 10.1016/j.thromres.2020.04.041</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.thromres.2020.04.041</ArticleId><ArticleId IdType="pmc">PMC7192101</ArticleId><ArticleId IdType="pubmed">32381264</ArticleId></ArticleIdList></Reference><Reference><Citation>Yong SJ. Long COVID or post-COVID-19 syndrome: putative pathophysiology, risk factors, and treatments. Infect Dis. (2021) 53:737&#x2013;54. 10.1080/23744235.2021.1924397</Citation><ArticleIdList><ArticleId IdType="doi">10.1080/23744235.2021.1924397</ArticleId><ArticleId IdType="pmc">PMC8146298</ArticleId><ArticleId IdType="pubmed">34024217</ArticleId></ArticleIdList></Reference><Reference><Citation>Shah W, Hillman T, Playford ED, Hishmeh L. Managing the long term effects of covid-19: summary of NICE, SIGN, and RCGP rapid guideline. BMJ. (2021) 372:n136. 10.1136/bmj.n136</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmj.n136</ArticleId><ArticleId IdType="pubmed">33483331</ArticleId></ArticleIdList></Reference><Reference><Citation>Datta S, Talwar A, Lee JTA. Proposed framework and timeline of the spectrum of disease due to SARS-CoV-2 infection: illness beyond acute infection and public health implications. JAMA. (2020) 324:2251&#x2013;2. 10.1001/jama.2020.22717</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2020.22717</ArticleId><ArticleId IdType="pubmed">33206133</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang C, Huang L, Wang Y, Li X, Ren L, Gu X, et al. 6-month consequences of COVID-19 in patients discharged from hospital: a cohort study. Lancet. (2021) 397:220&#x2013;32. 10.1016/S0140-6736(20)32656-8</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0140-6736(20)32656-8</ArticleId><ArticleId IdType="pmc">PMC7833295</ArticleId><ArticleId IdType="pubmed">33428867</ArticleId></ArticleIdList></Reference><Reference><Citation>Carf&#xec; A, Bernabei R, Landi F. Persistent symptoms in patients after acute COVID-19. JAMA. (2020) 324:603&#x2013;5. 10.1001/jama.2020.12603</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2020.12603</ArticleId><ArticleId IdType="pmc">PMC7349096</ArticleId><ArticleId IdType="pubmed">32644129</ArticleId></ArticleIdList></Reference><Reference><Citation>Nalbandian A, Sehgal K, Gupta A, Madhavan M, McGroder C, Stevens J, et al. Post-acute COVID-19 syndrome. Nat Med. (2021) 27:601&#x2013;15. 10.1038/s41591-021-01283-z</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-021-01283-z</ArticleId><ArticleId IdType="pmc">PMC8893149</ArticleId><ArticleId IdType="pubmed">33753937</ArticleId></ArticleIdList></Reference><Reference><Citation>Huang Y, Tan C, Wu J, Chen M, Wang Z, Luo L, et al. Impact of coronavirus disease 2019 on pulmonary function in early convalescence phase. Respir Res. (2020) 21:163. 10.1186/s12931-020-01429-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s12931-020-01429-6</ArticleId><ArticleId IdType="pmc">PMC7323373</ArticleId><ArticleId IdType="pubmed">32600344</ArticleId></ArticleIdList></Reference><Reference><Citation>Patell R, Bogue T, Koshy A, Bindal P, Merrill M, Aird W, et al. Postdischarge thrombosis and hemorrhage in patients with COVID-19. Blood. (2020) 136:1342&#x2013;6. 10.1182/blood.2020007938</Citation><ArticleIdList><ArticleId IdType="doi">10.1182/blood.2020007938</ArticleId><ArticleId IdType="pmc">PMC7483433</ArticleId><ArticleId IdType="pubmed">32766883</ArticleId></ArticleIdList></Reference><Reference><Citation>Heneka MT, Golenbock D, Latz E, Morgan D, Brown R. Immediate and long-term consequences of COVID-19 infections for the development of neurological disease. Alzheimers Res Ther. (2020) 12:69. 10.1186/s13195-020-00640-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1186/s13195-020-00640-3</ArticleId><ArticleId IdType="pmc">PMC7271826</ArticleId><ArticleId IdType="pubmed">32498691</ArticleId></ArticleIdList></Reference><Reference><Citation>Zubair AS, McAlpine LS, Gardin T, Farhadian S, Kuruvilla DE, Spudich S. Neuropathogenesis and neurologic manifestations of the coronaviruses in the age of coronavirus disease 2019: a review. JAMA Neurol. (2020) 77:1018&#x2013;27. 10.1001/jamaneurol.2020.2065</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamaneurol.2020.2065</ArticleId><ArticleId IdType="pmc">PMC7484225</ArticleId><ArticleId IdType="pubmed">32469387</ArticleId></ArticleIdList></Reference><Reference><Citation>Stevens JS, King KL, Robbins-Juarez SY, Khairallah P, Toma K, Alvarado Verduzco H, et al. High rate of renal recovery in survivors of COVID-19 associated acute renal failure requiring renal replacement therapy. PLoS One. (2020) 15:e0244131. 10.1371/journal.pone.0244131</Citation><ArticleIdList><ArticleId IdType="doi">10.1371/journal.pone.0244131</ArticleId><ArticleId IdType="pmc">PMC7769434</ArticleId><ArticleId IdType="pubmed">33370368</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang S, Bai W, Yue J, Qin L, Zhang C, Xu S, et al. Eight months follow-up study on pulmonary function, lung radiographic, and related physiological characteristics in COVID-19 survivors. Sci Rep. (2021) 11:13854. 10.1038/s41598-021-93191-y</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-021-93191-y</ArticleId><ArticleId IdType="pmc">PMC8257634</ArticleId><ArticleId IdType="pubmed">34226597</ArticleId></ArticleIdList></Reference><Reference><Citation>Chung M, Bernheim A, Mei X, Zhang N, Huang M, Zeng X, et al. CT imaging features of 2019 novel coronavirus (2019-nCoV). Radiology. (2020) 295:202&#x2013;7. 10.1148/radiol.2020200230</Citation><ArticleIdList><ArticleId IdType="doi">10.1148/radiol.2020200230</ArticleId><ArticleId IdType="pmc">PMC7194022</ArticleId><ArticleId IdType="pubmed">32017661</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu C, Ye L, Xia R, Zheng X, Yuan C, Wang Z, et al. Chest computed tomography and clinical follow-up of discharged patients with COVID-19 in Wenzhou City, Zhejiang, China. Ann Am Thorac Soc. (2020) 17:1231&#x2013;7. 10.1513/AnnalsATS.202004-324OC</Citation><ArticleIdList><ArticleId IdType="doi">10.1513/AnnalsATS.202004-324OC</ArticleId><ArticleId IdType="pmc">PMC7640627</ArticleId><ArticleId IdType="pubmed">32692945</ArticleId></ArticleIdList></Reference><Reference><Citation>Li K, Wu J, Wu F, Guo D, Chen L, Fang Z, et al. The clinical and chest CT features associated with severe and critical COVID-19 Pneumonia. Invest Radiol. (2020) 55:327&#x2013;31. 10.1097/RLI.0000000000000672</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/RLI.0000000000000672</ArticleId><ArticleId IdType="pmc">PMC7147273</ArticleId><ArticleId IdType="pubmed">32118615</ArticleId></ArticleIdList></Reference><Reference><Citation>Guler SA, Ebner L, Aubry-Beigelman C, Bridevaux PO, Brutsche M, Clarenbach C, et al. Pulmonary function and radiological features 4 months after COVID-19: first results from the national prospective observational Swiss COVID-19 lung study. Eur Respir J. (2021) 57:2003690. 10.1183/13993003.03690-2020</Citation><ArticleIdList><ArticleId IdType="doi">10.1183/13993003.03690-2020</ArticleId><ArticleId IdType="pmc">PMC8082329</ArticleId><ArticleId IdType="pubmed">33419891</ArticleId></ArticleIdList></Reference><Reference><Citation>Qin W, Chen S, Zhang Y, Dong F, Zhang Z, Hu B, et al. Diffusion capacity abnormalities for carbon monoxide in patients with COVID-19 at 3-month follow-up. Eur Respir J. (2021) 58:2003677. 10.1183/13993003.03677-2020</Citation><ArticleIdList><ArticleId IdType="doi">10.1183/13993003.03677-2020</ArticleId><ArticleId IdType="pmc">PMC7877322</ArticleId><ArticleId IdType="pubmed">33574077</ArticleId></ArticleIdList></Reference><Reference><Citation>Al-Samkari H, Karp Leaf RS, Dzik WH, Carlson JC, Fogerty AE, Waheed A, et al. COVID-19 and coagulation: bleeding and thrombotic manifestations of SARS-CoV-2 infection. Blood. (2020) 136:489&#x2013;500. 10.1182/blood.2020006520</Citation><ArticleIdList><ArticleId IdType="doi">10.1182/blood.2020006520</ArticleId><ArticleId IdType="pmc">PMC7378457</ArticleId><ArticleId IdType="pubmed">32492712</ArticleId></ArticleIdList></Reference><Reference><Citation>Blanco-Melo D, Nilsson-Payant BE, Liu WC, Uhl S, Hoagland D, M&#xf8;ller R, et al. Imbalanced host response to SARS-CoV-2 drives development of COVID-19. Cell. (2020) 181:1036.e&#x2013;45.e. 10.1016/j.cell.2020.04.026</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cell.2020.04.026</ArticleId><ArticleId IdType="pmc">PMC7227586</ArticleId><ArticleId IdType="pubmed">32416070</ArticleId></ArticleIdList></Reference><Reference><Citation>L&#xf3;pez-Cort&#xe9;s A, Guerrero S, Ortiz-Prado E, Yumiceba V, Vera-Guapi A, Le&#xf3;n C&#xe1;ceres &#xc1;, et al. Pulmonary inflammatory response in lethal COVID-19 reveals potential therapeutic targets and drugs in phases III/IV clinical trials. Front Pharmacol. (2022) 13:833174. 10.3389/fphar.2022.833174</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fphar.2022.833174</ArticleId><ArticleId IdType="pmc">PMC9002106</ArticleId><ArticleId IdType="pubmed">35422702</ArticleId></ArticleIdList></Reference><Reference><Citation>McKechnie JL, Blish CA. The innate immune system: fighting on the front lines or fanning the flames of COVID-19? Cell Host Microbe. (2020) 27:863&#x2013;9. 10.1016/j.chom.2020.05.009</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.chom.2020.05.009</ArticleId><ArticleId IdType="pmc">PMC7237895</ArticleId><ArticleId IdType="pubmed">32464098</ArticleId></ArticleIdList></Reference><Reference><Citation>Ruan Q, Yang K, Wang W, Jiang L, Song J. Clinical predictors of mortality due to COVID-19 based on an analysis of data of 150 patients from Wuhan, China. Intensive Care Med. (2020) 46:846&#x2013;8. 10.1007/s00134-020-05991-x</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s00134-020-05991-x</ArticleId><ArticleId IdType="pmc">PMC7080116</ArticleId><ArticleId IdType="pubmed">32125452</ArticleId></ArticleIdList></Reference><Reference><Citation>von Elm E, Altman DG, Egger M, Pocock SJ, G&#xf8;tzsche PC, Vandenbroucke JP. The strengthening the reporting of observational studies in epidemiology (STROBE) statement: guidelines for reporting observational studies. PLoS Med. (2007) 4:e296. 10.1097/EDE.0b013e3181577511</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/EDE.0b013e3181577511</ArticleId><ArticleId IdType="pmc">PMC2020495</ArticleId><ArticleId IdType="pubmed">17941714</ArticleId></ArticleIdList></Reference><Reference><Citation>Cheng H, Sebaa R, Malholtra N, Lacoste B, El Hankouri Z, Kirby A, et al. Naked mole-rat brown fat thermogenesis is diminished during hypoxia through a rapid decrease in UCP1. Nature Communications. (2021) 12:6801. 10.1038/s41467-021-27170-2</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41467-021-27170-2</ArticleId><ArticleId IdType="pmc">PMC8610999</ArticleId><ArticleId IdType="pubmed">34815412</ArticleId></ArticleIdList></Reference><Reference><Citation>Labarca G, Henr&#xed;quez-Beltr&#xe1;n M, Lastra J, Enos D, Llerena F, Cigarroa I, et al. Analysis of clinical symptoms, radiological changes and pulmonary function data 4 months after COVID-19. Clin Respir J. (2021) 15:992&#x2013;1002. 10.1111/crj.13403</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/crj.13403</ArticleId><ArticleId IdType="pmc">PMC8239617</ArticleId><ArticleId IdType="pubmed">34086416</ArticleId></ArticleIdList></Reference><Reference><Citation>ATS Committee on Proficiency Standards for Clinical Pulmonary Function Laboratories. ATS statement: guidelines for the six-minute walk test. Am J Respir Crit Care Med. (2002) 166:111&#x2013;7. 10.1164/ajrccm.166.1.at1102</Citation><ArticleIdList><ArticleId IdType="doi">10.1164/ajrccm.166.1.at1102</ArticleId><ArticleId IdType="pubmed">12091180</ArticleId></ArticleIdList></Reference><Reference><Citation>Romero-Dapueto C, Mahn J, Cavada G, Daza R, Ulloa V, Ant&#xfa;nez M. Hand grip strength values in normal Chilean subjects. Rev Med Chil. (2019) 147:741&#x2013;50. 10.4067/S0034-98872019000600741</Citation><ArticleIdList><ArticleId IdType="doi">10.4067/S0034-98872019000600741</ArticleId><ArticleId IdType="pubmed">31859827</ArticleId></ArticleIdList></Reference><Reference><Citation>Araya JI. Percepci&#xf3;n de esfuerzo f&#xed;sico mediante uso de escala de Borg. de Chile: Instituto de Salud P&#xfa;blica de Chile; (2019).</Citation></Reference><Reference><Citation>Chawla N, Bowyer K, Hall L, Kegelmeyer W. SMOTE: synthetic minority over-sampling technique. J Artif Intell Res. (2002) 16:321&#x2013;57. 10.1613/jair.953</Citation><ArticleIdList><ArticleId IdType="doi">10.1613/jair.953</ArticleId></ArticleIdList></Reference><Reference><Citation>Pedregosa F, Varoquaux G, Gramfort A, Michel V, Thirion B, Grisel O, et al. Scikit-learn: machine learning in python. J Mach Learn Res. (2011) 12:2825&#x2013;30.</Citation></Reference><Reference><Citation>Lundberg S, Lee S. A unified approach to interpreting model predictions. ArXiv [Preprint]. (2017)</Citation></Reference><Reference><Citation>Kong A, Leprevost F, Avtonomov D, Mellacheruvu D, Nesvizhskii A. MSFragger: ultrafast and comprehensive peptide identification in mass spectrometry-based proteomics. Nat Methods. (2017) 14:513&#x2013;20. 10.1038/nmeth.4256</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/nmeth.4256</ArticleId><ArticleId IdType="pmc">PMC5409104</ArticleId><ArticleId IdType="pubmed">28394336</ArticleId></ArticleIdList></Reference><Reference><Citation>Yu F, Haynes S, Teo G, Avtonomov D, Polasky D, Nesvizhskii A. Fast quantitative analysis of timsTOF PASEF data with MSFragger and IonQuant. Mol Cell Proteomics. (2020) 19:1575&#x2013;85. 10.1074/mcp.TIR120.002048</Citation><ArticleIdList><ArticleId IdType="doi">10.1074/mcp.TIR120.002048</ArticleId><ArticleId IdType="pmc">PMC7996969</ArticleId><ArticleId IdType="pubmed">32616513</ArticleId></ArticleIdList></Reference><Reference><Citation>da Veiga Leprevost F, Haynes S, Avtonomov D, Chang H, Shanmugam A, Mellacheruvu D, et al. Philosopher: a versatile toolkit for shotgun proteomics data analysis. Nat Methods. (2020) 17:869&#x2013;70. 10.1038/s41592-020-0912-y</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41592-020-0912-y</ArticleId><ArticleId IdType="pmc">PMC7509848</ArticleId><ArticleId IdType="pubmed">32669682</ArticleId></ArticleIdList></Reference><Reference><Citation>R Core Team. RStudio: integrated development for R. Vienna: R Core Team; (2018).</Citation></Reference><Reference><Citation>Stekhoven D, B&#xfc;hlmann P. MissForest&#x2013;non-parametric missing value imputation for mixed-type data. Bioinformatics. (2012) 28:112&#x2013;8. 10.1093/bioinformatics/btr597</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/bioinformatics/btr597</ArticleId><ArticleId IdType="pubmed">22039212</ArticleId></ArticleIdList></Reference><Reference><Citation>Smyth G. Linear models and empirical bayes methods for assessing differential expression in microarray experiments. Stat Appl Genet Mol Biol. (2004) 3:Article3. 10.2202/1544-6115.1027</Citation><ArticleIdList><ArticleId IdType="doi">10.2202/1544-6115.1027</ArticleId><ArticleId IdType="pubmed">16646809</ArticleId></ArticleIdList></Reference><Reference><Citation>Blighe K. Enhancedvolcano: Publication-ready volcano plots with enhanced colouring and labeling. San Francisco, CA: GitHub; (2022).</Citation></Reference><Reference><Citation>Gu Z, Eils R, Schlesner M. Complex heatmaps reveal patterns and correlations in multidimensional genomic data. Bioinformatics. (2016) 32:2847&#x2013;9. 10.1093/bioinformatics/btw313</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/bioinformatics/btw313</ArticleId><ArticleId IdType="pubmed">27207943</ArticleId></ArticleIdList></Reference><Reference><Citation>Krijthe JH. Rtsne: T-distributed stochastic neighbor embedding using Barnes-Hut implementation. San Francisco, CA: GitHub; (2015).</Citation></Reference><Reference><Citation>Gandhi R, Lynch J, Del Rio C. Mild or Moderate Covid-19. N Engl J Med. (2020) 383:1757&#x2013;66. 10.1056/NEJMcp2009249</Citation><ArticleIdList><ArticleId IdType="doi">10.1056/NEJMcp2009249</ArticleId><ArticleId IdType="pubmed">32329974</ArticleId></ArticleIdList></Reference><Reference><Citation>Kierans S, Taylor C. Regulation of glycolysis by the hypoxia-inducible factor (HIF): implications for cellular physiology. J Physiol. (2021) 599:23&#x2013;37. 10.1113/JP280572</Citation><ArticleIdList><ArticleId IdType="doi">10.1113/JP280572</ArticleId><ArticleId IdType="pubmed">33006160</ArticleId></ArticleIdList></Reference><Reference><Citation>Wang R, Bao W, Pal M, Liu Y, Yazdanbakhsh K, Zhong H. Intermediate monocytes induced by IFN-&#x3b3; inhibit cancer metastasis by promoting NK cell activation through FOXO1 and interleukin-27. J Immunother Cancer. (2022) 10:e003539. 10.1136/jitc-2021-003539</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/jitc-2021-003539</ArticleId><ArticleId IdType="pmc">PMC8804695</ArticleId><ArticleId IdType="pubmed">35091454</ArticleId></ArticleIdList></Reference><Reference><Citation>Labarca G, Henriquez-Beltran M, Llerena F, Erices G, Lastra J, Enos D, et al. Undiagnosed sleep disorder breathing as a risk factor for critical COVID-19 and pulmonary consequences at the midterm follow-up. Sleep Med. (2022) 91:196&#x2013;204. 10.1016/j.sleep.2021.02.029</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.sleep.2021.02.029</ArticleId><ArticleId IdType="pmc">PMC7892300</ArticleId><ArticleId IdType="pubmed">33678579</ArticleId></ArticleIdList></Reference><Reference><Citation>Sansone A, Mollaioli D, Limoncin E, Ciocca G, B&#x1eaf;c N, Cao T. The sexual long COVID (SLC): erectile dysfunction as a biomarker of systemic complications for COVID-19 Long Haulers. Sex Med Rev. (2022) 10:271&#x2013;85. 10.1016/j.sxmr.2021.11.001</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.sxmr.2021.11.001</ArticleId><ArticleId IdType="pmc">PMC8604714</ArticleId><ArticleId IdType="pubmed">34933829</ArticleId></ArticleIdList></Reference><Reference><Citation>Henr&#xed;quez-Beltr&#xe1;n M, Cigarroa I, Enos D, Lastra J, Nova-Lamperti E, Labarca G. Evaluaci&#xf3;n de la salud sexual, mental y sue&#xf1;o en hombres chilenos posterior a infecci&#xf3;n por SARS-CoV-2. Revista m&#xe9;dica de Chile. (2022) 150:744&#x2013;53. 10.4067/S0034-98872022000600744</Citation><ArticleIdList><ArticleId IdType="doi">10.4067/S0034-98872022000600744</ArticleId><ArticleId IdType="pubmed">37906909</ArticleId></ArticleIdList></Reference><Reference><Citation>Gonz&#xe1;lez J, Ben&#xed;tez I, Carmona P, Santisteve S, Monge A, Moncus&#xed;-Moix A, et al. Pulmonary function and radiologic features in survivors of critical COVID-19: a 3-month prospective cohort. Chest. (2021) 160:187&#x2013;98. 10.1016/j.chest.2020.12.057</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.chest.2020.12.057</ArticleId><ArticleId IdType="pmc">PMC7930807</ArticleId><ArticleId IdType="pubmed">33676998</ArticleId></ArticleIdList></Reference><Reference><Citation>Solomon J, Heyman B, Ko J, Condos R, Lynch DA. CT of post-acute lung complications of COVID-19. Radiology. (2021) 301:E383&#x2013;95. 10.1148/radiol.2021211396</Citation><ArticleIdList><ArticleId IdType="doi">10.1148/radiol.2021211396</ArticleId><ArticleId IdType="pmc">PMC8369881</ArticleId><ArticleId IdType="pubmed">34374591</ArticleId></ArticleIdList></Reference><Reference><Citation>Bellan M, Soddu D, Balbo P, Baricich A, Zeppegno P, Avanzi G, et al. Respiratory and psychophysical sequelae among patients with COVID-19 four months after hospital discharge. JAMA Netw Open. (2021) 4:e2036142. 10.1001/jamanetworkopen.2020.36142</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jamanetworkopen.2020.36142</ArticleId><ArticleId IdType="pmc">PMC7841464</ArticleId><ArticleId IdType="pubmed">33502487</ArticleId></ArticleIdList></Reference><Reference><Citation>Xiong Y, Sun D, Liu Y, Fan Y, Zhao L, Li X, et al. Clinical and high-resolution CT features of the COVID-19 infection: comparison of the initial and follow-up changes. Invest Radiol. (2020) 55:332&#x2013;9. 10.1097/RLI.0000000000000674</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/RLI.0000000000000674</ArticleId><ArticleId IdType="pmc">PMC7147282</ArticleId><ArticleId IdType="pubmed">32134800</ArticleId></ArticleIdList></Reference><Reference><Citation>Gonz&#xe1;lez J, Ben&#xed;tez I, de Gonzalo-Calvo D, Torres G, de Batlle J, G&#xf3;mez S, et al. Impact of time to intubation on mortality and pulmonary sequelae in critically ill patients with COVID-19: a prospective cohort study. Crit Care. (2022) 26:18.</Citation><ArticleIdList><ArticleId IdType="pmc">PMC8744383</ArticleId><ArticleId IdType="pubmed">35012662</ArticleId></ArticleIdList></Reference><Reference><Citation>Gonz&#xe1;lez J, Zuil M, Ben&#xed;tez ID, de Gonzalo-Calvo D, Aguilar M, Santisteve S, et al. One year overview and Follow-Up in a post-COVID consultation of critically ill patients. Front Med (Lausanne). (2022) 9:897990. 10.3389/fmed.2022.897990</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmed.2022.897990</ArticleId><ArticleId IdType="pmc">PMC9329578</ArticleId><ArticleId IdType="pubmed">35911414</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou M, Xu J, Liao T, Yin Z, Yang F, Wang K, et al. Comparison of residual pulmonary abnormalities 3 months after discharge in patients who recovered from COVID-19 of different severity. Front Med. (2021) 8:682087. 10.3389/fmed.2021.682087</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmed.2021.682087</ArticleId><ArticleId IdType="pmc">PMC8270002</ArticleId><ArticleId IdType="pubmed">34249973</ArticleId></ArticleIdList></Reference><Reference><Citation>Bartolucci M, Benelli M, Betti M, Bicchi S, Fedeli L, Giannelli F, et al. The incremental value of computed tomography of COVID-19 pneumonia in predicting ICU admission. Sci Rep. (2021) 11:15619. 10.1038/s41598-021-95114-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-021-95114-3</ArticleId><ArticleId IdType="pmc">PMC8329253</ArticleId><ArticleId IdType="pubmed">34341411</ArticleId></ArticleIdList></Reference><Reference><Citation>Gordo Vidal F, Delgado Arnaiz C, Calvo Herranz E. [Mechanical ventilation induced lung injury]. Med Intensiva. (2007) 31:18&#x2013;26. 10.1016/S0210-5691(07)74765-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S0210-5691(07)74765-4</ArticleId><ArticleId IdType="pubmed">17306136</ArticleId></ArticleIdList></Reference><Reference><Citation>Slutsky A, Tremblay L. Multiple system organ failure. Is mechanical ventilation a contributing factor? Am J Respir Crit Care Med. (1998) 157:1721&#x2013;5. 10.1164/ajrccm.157.6.9709092</Citation><ArticleIdList><ArticleId IdType="doi">10.1164/ajrccm.157.6.9709092</ArticleId><ArticleId IdType="pubmed">9620897</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhou M, Yin Z, Xu J, Wang S, Liao T, Wang K, et al. inflammatory profiles and clinical features of coronavirus 2019 survivors 3 months after discharge in Wuhan, China. J Infect Dis. (2021) 224:1473&#x2013;88. 10.1093/infdis/jiab181</Citation><ArticleIdList><ArticleId IdType="doi">10.1093/infdis/jiab181</ArticleId><ArticleId IdType="pmc">PMC8083630</ArticleId><ArticleId IdType="pubmed">33822106</ArticleId></ArticleIdList></Reference><Reference><Citation>Calabrese C, Annunziata A, Flora M, Mariniello D, Allocca V, Palma M, et al. Three month follow-up of patients with COVID-19 pneumonia complicated by pulmonary embolism. Front Mol Biosci. (2021) 8:809186. 10.3389/fmolb.2021.809186</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmolb.2021.809186</ArticleId><ArticleId IdType="pmc">PMC8850371</ArticleId><ArticleId IdType="pubmed">35187074</ArticleId></ArticleIdList></Reference><Reference><Citation>Torres-Castro R, Vasconcello-Castillo L, Alsina-Restoy X, Solis-Navarro L, Burgos F, Puppo H, et al. Respiratory function in patients post-infection by COVID-19: a systematic review and meta-analysis. Pulmonology. (2021) 27:328&#x2013;37. 10.1016/j.pulmoe.2020.10.013</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.pulmoe.2020.10.013</ArticleId><ArticleId IdType="pmc">PMC7687368</ArticleId><ArticleId IdType="pubmed">33262076</ArticleId></ArticleIdList></Reference><Reference><Citation>Zhang H, Li X, Huang L, Gu X, Wang Y, Liu M, et al. Lung-function trajectories in COVID-19 survivors after discharge: a two-year longitudinal cohort study. EClinicalMedicine. (2022) 54:101668. 10.1016/j.eclinm.2022.101668</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.eclinm.2022.101668</ArticleId><ArticleId IdType="pmc">PMC9514976</ArticleId><ArticleId IdType="pubmed">36188433</ArticleId></ArticleIdList></Reference><Reference><Citation>Gonz&#xe1;lez J, Zuil M, Ben&#xed;tez I, de Batlle J, Aguil&#xe0; M, Santisteve S, et al. Long-term outcomes in critical COVID-19 survivors: a 2-year longitudinal cohort. Arch Bronconeumol. (2023) 10.1016/j.arbres.2023.08.006 [Epub ahead of print].</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.arbres.2023.08.006</ArticleId><ArticleId IdType="pubmed">37640655</ArticleId></ArticleIdList></Reference><Reference><Citation>Liu Q, Cheng A, Wang Y, Li H, Hu L, Zhao X, et al. Cytokines and their relationship with the severity and prognosis of coronavirus disease 2019 (COVID-19): a retrospective cohort study. BMJ Open. (2020) 10:e041471. 10.1136/bmjopen-2020-041471</Citation><ArticleIdList><ArticleId IdType="doi">10.1136/bmjopen-2020-041471</ArticleId><ArticleId IdType="pmc">PMC7705426</ArticleId><ArticleId IdType="pubmed">33257492</ArticleId></ArticleIdList></Reference><Reference><Citation>L&#xf3;pez-Cort&#xe9;s A, Guevara-Ram&#xed;rez P, Kyriakidis N, Barba-Ostria C, Le&#xf3;n C&#xe1;ceres &#xc1;, Guerrero S, et al. In silico analyses of immune system protein interactome network, single-cell RNA Sequencing of human tissues, and artificial neural networks reveal potential therapeutic targets for drug repurposing against COVID-19. Front Pharmacol. (2021) 12:598925. 10.3389/fphar.2021.598925</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fphar.2021.598925</ArticleId><ArticleId IdType="pmc">PMC7952300</ArticleId><ArticleId IdType="pubmed">33716737</ArticleId></ArticleIdList></Reference><Reference><Citation>Song C, Xu J, He J, Lu Y. Immune dysfunction following COVID-19, especially in severe patients. Sci Rep. (2020) 10:15838. 10.1038/s41598-020-72718-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41598-020-72718-9</ArticleId><ArticleId IdType="pmc">PMC7522270</ArticleId><ArticleId IdType="pubmed">32985562</ArticleId></ArticleIdList></Reference><Reference><Citation>Castell J, G&#xf3;mez-Lech&#xf3;n M, David M, Andus T, Geiger T, Trullenque R, et al. Interleukin-6 is the major regulator of acute phase protein synthesis in adult human hepatocytes. FEBS Lett. (1989) 242:237&#x2013;9. 10.1016/0014-5793(89)80476-4</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/0014-5793(89)80476-4</ArticleId><ArticleId IdType="pubmed">2464504</ArticleId></ArticleIdList></Reference><Reference><Citation>Kuan W, Tam L, Wong C, Ko F, Li T, Zhu T, et al. CXCL 9 and CXCL 10 as Sensitive markers of disease activity in patients with rheumatoid arthritis. J Rheumatol. (2010) 37:257&#x2013;64. 10.3899/jrheum.090769</Citation><ArticleIdList><ArticleId IdType="doi">10.3899/jrheum.090769</ArticleId><ArticleId IdType="pubmed">20032101</ArticleId></ArticleIdList></Reference><Reference><Citation>Zang J, Ye J, Zhang C, Sha M, Gao J. Senescent hepatocytes enhance natural killer cell activity via the CXCL-10/CXCR3 axis. Exp Ther Med. (2019) 18:3845&#x2013;52. 10.3892/etm.2019.8037</Citation><ArticleIdList><ArticleId IdType="doi">10.3892/etm.2019.8037</ArticleId><ArticleId IdType="pmc">PMC6781833</ArticleId><ArticleId IdType="pubmed">31616512</ArticleId></ArticleIdList></Reference><Reference><Citation>Sanz JM, G&#xf3;mez Lahoz AM, Mart&#xed;n RO. Role of the immune system in SARS-CoV-2 infection: immunopathology of COVID-19. Medicine. (2021) 13:1917&#x2013;31. 10.1016/j.med.2021.05.005</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.med.2021.05.005</ArticleId><ArticleId IdType="pmc">PMC8158328</ArticleId><ArticleId IdType="pubmed">34075268</ArticleId></ArticleIdList></Reference><Reference><Citation>Yan B, Freiwald T, Chauss D, Wang L, West E, Mirabelli C, et al. SARS-CoV-2 drives JAK1/2-dependent local complement hyperactivation. Sci Immunol. (2021) 6:eabg0833. 10.1126/sciimmunol.abg0833</Citation><ArticleIdList><ArticleId IdType="doi">10.1126/sciimmunol.abg0833</ArticleId><ArticleId IdType="pmc">PMC8139422</ArticleId><ArticleId IdType="pubmed">33827897</ArticleId></ArticleIdList></Reference><Reference><Citation>Lan L, Xu D, Ye G, Xia C, Wang S, Li Y, et al. Positive RT-PCR test results in patients recovered from COVID-19. JAMA. (2020) 323:1502&#x2013;3. 10.1001/jama.2020.2783</Citation><ArticleIdList><ArticleId IdType="doi">10.1001/jama.2020.2783</ArticleId><ArticleId IdType="pmc">PMC7047852</ArticleId><ArticleId IdType="pubmed">32105304</ArticleId></ArticleIdList></Reference><Reference><Citation>Proal A, VanElzakker M. Long COVID or post-acute sequelae of COVID-19 (PASC): an overview of biological factors that may contribute to persistent symptoms. Front Microbiol. (2021) 12:698169. 10.3389/fmicb.2021.698169</Citation><ArticleIdList><ArticleId IdType="doi">10.3389/fmicb.2021.698169</ArticleId><ArticleId IdType="pmc">PMC8260991</ArticleId><ArticleId IdType="pubmed">34248921</ArticleId></ArticleIdList></Reference><Reference><Citation>Magadum A, Kishore R. Cardiovascular manifestations of COVID-19 infection. Cells. (2020) 9:2508. 10.3390/cells9112508</Citation><ArticleIdList><ArticleId IdType="doi">10.3390/cells9112508</ArticleId><ArticleId IdType="pmc">PMC7699571</ArticleId><ArticleId IdType="pubmed">33228225</ArticleId></ArticleIdList></Reference><Reference><Citation>Pierce J, Shen Q, Cintron S, Hiebert J. Post-COVID-19 Syndrome. Nurs Res. (2022) 71:164&#x2013;74. 10.1097/NNR.0000000000000565</Citation><ArticleIdList><ArticleId IdType="doi">10.1097/NNR.0000000000000565</ArticleId><ArticleId IdType="pubmed">34653099</ArticleId></ArticleIdList></Reference><Reference><Citation>Xie Y, Xu E, Bowe B, Al-Aly Z. Long-term cardiovascular outcomes of COVID-19. Nat Med. (2022) 28:583&#x2013;90. 10.1038/s41591-022-01689-3</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41591-022-01689-3</ArticleId><ArticleId IdType="pmc">PMC8938267</ArticleId><ArticleId IdType="pubmed">35132265</ArticleId></ArticleIdList></Reference><Reference><Citation>Bonaventura A, Vecchi&#xe9; A, Dagna L, Martinod K, Dixon D, Van Tassell B, et al. Endothelial dysfunction and immunothrombosis as key pathogenic mechanisms in COVID-19. Nat Rev Immunol. (2021) 21:319&#x2013;29. 10.1038/s41577-021-00536-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41577-021-00536-9</ArticleId><ArticleId IdType="pmc">PMC8023349</ArticleId><ArticleId IdType="pubmed">33824483</ArticleId></ArticleIdList></Reference><Reference><Citation>Umesh A, Pranay K, Pandey R, Gupta M. Evidence mapping and review of long-COVID and its underlying pathophysiological mechanism. Infection. (2022) 50:1053&#x2013;66. 10.1007/s15010-022-01835-6</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s15010-022-01835-6</ArticleId><ArticleId IdType="pmc">PMC9055372</ArticleId><ArticleId IdType="pubmed">35489015</ArticleId></ArticleIdList></Reference><Reference><Citation>Carvalho-Schneider C, Laurent E, Lemaignen A, Beaufils E, Bourbao-Tournois C, Laribi S, et al. Follow-up of adults with noncritical COVID-19 two months after symptom onset. Clin Microbiol Infect. (2021) 27:258&#x2013;63. 10.1016/j.cmi.2020.09.052</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.cmi.2020.09.052</ArticleId><ArticleId IdType="pmc">PMC7534895</ArticleId><ArticleId IdType="pubmed">33031948</ArticleId></ArticleIdList></Reference><Reference><Citation>Davis H, Assaf G, McCorkell L, Wei H, Low R, Re&#x2019;em Y, et al. Characterizing long COVID in an international cohort: 7 months of symptoms and their impact. EClinicalMedicine. (2021) 38:101019. 10.1016/j.eclinm.2021.101019</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.eclinm.2021.101019</ArticleId><ArticleId IdType="pmc">PMC8280690</ArticleId><ArticleId IdType="pubmed">34308300</ArticleId></ArticleIdList></Reference><Reference><Citation>Wu X, Liu X, Zhou Y, Yu H, Li R, Zhan Q, et al. 3-month, 6-month, 9-month, and 12-month respiratory outcomes in patients following COVID-19-related hospitalisation: a prospective study. Lancet Respir Med. (2021) 9:747&#x2013;54. 10.1016/S2213-2600(21)00174-0</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/S2213-2600(21)00174-0</ArticleId><ArticleId IdType="pmc">PMC8099316</ArticleId><ArticleId IdType="pubmed">33964245</ArticleId></ArticleIdList></Reference><Reference><Citation>Anaya J, Rojas M, Salinas M, Rodr&#xed;guez Y, Roa G, Lozano M, et al. Post-COVID syndrome. A case series and comprehensive review. Autoimmun Rev. (2021) 20:102947. 10.1016/j.autrev.2021.102947</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.autrev.2021.102947</ArticleId><ArticleId IdType="pmc">PMC8428988</ArticleId><ArticleId IdType="pubmed">34509649</ArticleId></ArticleIdList></Reference><Reference><Citation>Al-Aly Z, Xie Y, Bowe B. High-dimensional characterization of post-acute sequelae of COVID-19. Nature. (2021) 594:259&#x2013;64. 10.1038/s41586-021-03553-9</Citation><ArticleIdList><ArticleId IdType="doi">10.1038/s41586-021-03553-9</ArticleId><ArticleId IdType="pubmed">33887749</ArticleId></ArticleIdList></Reference><Reference><Citation>Raveendran A, Misra A. Post COVID-19 Syndrome (&#x201d;Long COVID&#x201d;) and diabetes: challenges in diagnosis and management. Diabetes Metab Syndr. (2021) 15:102235. 10.1016/j.dsx.2021.102235</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.dsx.2021.102235</ArticleId><ArticleId IdType="pmc">PMC8317446</ArticleId><ArticleId IdType="pubmed">34384972</ArticleId></ArticleIdList></Reference><Reference><Citation>Chuang H, Lin C, Hsiao M, Wang T, Liang H. Long COVID and rehabilitation. J Formos Med Assoc. (2023) 10.1016/j.jfma.2023.03.022 [Epub ahead of print].</Citation><ArticleIdList><ArticleId IdType="doi">10.1016/j.jfma.2023.03.022</ArticleId><ArticleId IdType="pmc">PMC10101546</ArticleId><ArticleId IdType="pubmed">37061399</ArticleId></ArticleIdList></Reference><Reference><Citation>Halabchi F, Selk-Ghaffari M, Tazesh B, Mahdaviani B. The effect of exercise rehabilitation on COVID-19 outcomes: a systematic review of observational and intervention studies. Sport Sci Health. (2022) 18:1201&#x2013;19. 10.1007/s11332-022-00966-5</Citation><ArticleIdList><ArticleId IdType="doi">10.1007/s11332-022-00966-5</ArticleId><ArticleId IdType="pmc">PMC9244056</ArticleId><ArticleId IdType="pubmed">35789736</ArticleId></ArticleIdList></Reference><Reference><Citation>Jimeno-Almaz&#xe1;n A, Franco-L&#xf3;pez F, Buend&#xed;a-Romero &#xc1;, Mart&#xed;nez-Cava A, S&#xe1;nchez-Agar J, S&#xe1;nchez-Alcaraz Mart&#xed;nez B. Rehabilitation for post-COVID-19 condition through a supervised exercise intervention: A randomized controlled trial. Scand J Med Sci Sports. (2022) 32:1791&#x2013;801. 10.1111/sms.14240</Citation><ArticleIdList><ArticleId IdType="doi">10.1111/sms.14240</ArticleId><ArticleId IdType="pmc">PMC9538729</ArticleId><ArticleId IdType="pubmed">36111386</ArticleId></ArticleIdList></Reference><Reference><Citation>Nopp S, Moik F, Klok F, Gattinger D, Petrovic M, Vonbank K, et al. outpatient pulmonary rehabilitation in patients with long COVID improves exercise capacity, functional status, dyspnea, fatigue, and quality of life. Respiration. (2022) 101:593&#x2013;601. 10.1159/000522118</Citation><ArticleIdList><ArticleId IdType="doi">10.1159/000522118</ArticleId><ArticleId IdType="pmc">PMC9059007</ArticleId><ArticleId IdType="pubmed">35203084</ArticleId></ArticleIdList></Reference><Reference><Citation>Vanichkachorn G, Gilman E, Ganesh R, Mueller M, Swift M, Breeher L, et al. Potential reduction of post-acute sequelae of SARS-CoV-2 symptoms via vaccination. J Investig Med. (2023) 2023:10815589231191812. 10.1177/10815589231191812</Citation><ArticleIdList><ArticleId IdType="doi">10.1177/10815589231191812</ArticleId><ArticleId IdType="pubmed">37497990</ArticleId></ArticleIdList></Reference></ReferenceList></PubmedData></PubmedArticle></PubmedArticleSet>